<?xml version="1.0" encoding="UTF-8"?>

<article dtd-version="1.0" article-type="research-article">
   <front>
      <journal-meta>
         <journal-id xmlns:xlink="http://www.w3.org/1999/xlink" journal-id-type="jstor">j50019983</journal-id>
         <journal-id xmlns:xlink="http://www.w3.org/1999/xlink" journal-id-type="jcode">saeintejtransafe</journal-id>
         <journal-title-group>
            <journal-title>SAE International Journal of Transportation Safety</journal-title>
         </journal-title-group>
         <issn xmlns:xlink="http://www.w3.org/1999/xlink" pub-type="ppub">23275626</issn>
         <issn xmlns:xlink="http://www.w3.org/1999/xlink" pub-type="epub">23275634</issn>
         <publisher>
            <publisher-name specific-use="jstor-licensing-publisher">SAE International</publisher-name>
         </publisher>
      </journal-meta>
      <article-meta>
         <article-id xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="jstor">26897927</article-id>
         <title-group>
            <article-title>Driving Simulator Performance in Charcot-Marie-Tooth Disease Type 1A</article-title>
         </title-group>
         <contrib-group>
            <contrib contrib-type="author">
               <string-name xmlns:xlink="http://www.w3.org/1999/xlink">
                  <surname>Jerath</surname>
                  <given-names>Nivedita U.</given-names>
               </string-name>
            </contrib>
            <contrib contrib-type="author">
               <string-name xmlns:xlink="http://www.w3.org/1999/xlink">
                  <surname>Aksan</surname>
                  <given-names>Nazan</given-names>
               </string-name>
            </contrib>
            <contrib contrib-type="author">
               <string-name xmlns:xlink="http://www.w3.org/1999/xlink">
                  <surname>Dawson</surname>
                  <given-names>Jeffrey D.</given-names>
               </string-name>
            </contrib>
            <contrib contrib-type="author">
               <string-name xmlns:xlink="http://www.w3.org/1999/xlink">
                  <surname>Rizzo</surname>
                  <given-names>Matthew</given-names>
               </string-name>
            </contrib>
            <contrib contrib-type="author">
               <string-name xmlns:xlink="http://www.w3.org/1999/xlink">
                  <surname>Uc</surname>
                  <given-names>Ergun Y.</given-names>
               </string-name>
            </contrib>
            <contrib contrib-type="author">
               <string-name xmlns:xlink="http://www.w3.org/1999/xlink">
                  <surname>Shy</surname>
                  <given-names>Michael E.</given-names>
               </string-name>
            </contrib>
         </contrib-group>


         <pub-date xmlns:xlink="http://www.w3.org/1999/xlink"
                   xmlns:mml="http://www.w3.org/1998/Math/MathML"
                   xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">
            <day>1</day>
            <month>1</month>
            <year>2019</year>
            <string-date>2019</string-date>
         </pub-date>
         <volume xmlns:xlink="http://www.w3.org/1999/xlink">7</volume>
         <issue xmlns:xlink="http://www.w3.org/1999/xlink">1</issue>
         <issue-id xmlns:xlink="http://www.w3.org/1999/xlink">e26897924</issue-id>
         <fpage>31</fpage>
         <lpage>40</lpage>
         <permissions>
            <copyright-statement>Copyright © 2019 SAE International</copyright-statement>
         </permissions>
         <self-uri xmlns:xlink="http://www.w3.org/1999/xlink"
                   xlink:href="https://www.jstor.org/stable/26897927"/>
         <abstract xml:lang="eng">
            <sec>
               <label>Introduction:</label> 
               <p>This study evaluates driving ability in those with Charcot-Marie-Tooth Disease Type 1A, a hereditary peripheral neuropathy.</p>
            </sec>
            <sec>
               <label>Methods:</label> 
               <p>Individuals with Charcot-Marie-Tooth Disease Type 1A (n = 18, age = 42 ± 7) and controls (n = 19; age = 35 ± 10) were evaluated in a driving simulator. The Charcot-Marie-Tooth Neuropathy Score version 2 was obtained for individuals. Rank Sum test and Spearman rank correlations were used for statistical analysis.</p>
            </sec>
            <sec>
               <label>Results:</label> 
               <p>A 74% higher rate of lane departures and an 89% higher rate of lane deviations were seen in those with Charcot-Marie-Tooth Disease Type 1A than for controls (p = 0.005 and p &lt; 0.001, respectively). Lane control variability was 10% higher for the individual group and correlated with the neuropathy score (r<sub>S</sub> = 0.518, p = 0.040), specifically sensory loss (r<sub>S</sub> = 0.710, p = 0.002) and pinprick sensation loss in the leg (r<sub>S</sub> = 0.490, p = 0.054).</p>
            </sec>
            <sec>
               <label>Discussion:</label> 
               <p>Driving simulator assessment demonstrated more lane control errors in those with Charcot-Marie-Tooth Disease Type 1A, which correlated with lower extremity sensory loss. There was no significant difference in reported motor vehicle accidents.</p>
            </sec>
         </abstract>
         <custom-meta-group xmlns:xlink="http://www.w3.org/1999/xlink">
            <custom-meta>
               <meta-name>lang</meta-name>
               <meta-value>eng</meta-value>
            </custom-meta>
         </custom-meta-group>
      </article-meta>
   </front>
   <back>
      <ref-list content-type="unparsed-citations">
         <title>References</title>
         <ref id="r1">
            <label>1.</label>
            <mixed-citation id="c1">Cho, S.C., Katzberg, H.D., Rama, A. et al., “Driving with Polyneuropathy,” Muscle &amp; Nerve 41:324-328, 2010.</mixed-citation>
         </ref>
         <ref id="r2">
            <label>2.</label>
            <mixed-citation id="c2">Yale, S.H., Hansotia, P., Knapp, D., and Ehrfurth, J., “Neurologic Conditions: Assessing Medical Fitness to Drive,” Clinical Medicine &amp; Research 1:177-188, 2003.</mixed-citation>
         </ref>
         <ref id="r3">
            <label>3.</label>
            <mixed-citation id="c3">Meyr, A.J. and Spiess, K.E., “Diabetic Driving Studies-Part 1: Brake Response Time in Diabetic Drivers with Lower Extremity Neuropathy,” J Foot Ankle Surg 56:568-572, 2017.</mixed-citation>
         </ref>
         <ref id="r4">
            <label>4.</label>
            <mixed-citation id="c4">Skre, H., “Genetic and Clinical Aspects of Charcot-Marie-Tooth’s Disease,” Clinical Genetics 6:98-118, 1974.</mixed-citation>
         </ref>
         <ref id="r5">
            <label>5.</label>
            <mixed-citation id="c5">Burns, J., Menezes, M., Finkel, R.S. et al., “Transitioning Outcome Measures: Relationship between the CMTPedS and CMTNSv2 in Children, Adolescents, and Young Adults with Charcot-Marie-Tooth Disease,” Journal of the Peripheral Nervous System: JPNS 18:177-180, 2013.</mixed-citation>
         </ref>
         <ref id="r6">
            <label>6.</label>
            <mixed-citation id="c6">Thomas, P.K., Marques, W. Jr., Davis, M.B. et al., “The Phenotypic Manifestations of Chromosome 17p11.2 Duplication,” Brain: A Journal of Neurology 120(Pt 3):465- 478, 1997.</mixed-citation>
         </ref>
         <ref id="r7">
            <label>7.</label>
            <mixed-citation id="c7">Galvez-Garcia, G., Albayay, J., Rehbein, L., and Tornay, F., “Mitigating Simulator Adaptation Syndrome by Means of Tactile Stimulation,” Appl Ergon 58:13-17, 2017.</mixed-citation>
         </ref>
         <ref id="r8">
            <label>8.</label>
            <mixed-citation id="c8">Murphy, S.M., Herrmann, D.N., McDermott, M.P. et al., “Reliability of the CMT Neuropathy Score (Second Version) in Charcot-Marie-Tooth Disease,” Journal of the Peripheral Nervous System: JPNS 16:191-198, 2011.</mixed-citation>
         </ref>
         <ref id="r9">
            <label>9.</label>
            <mixed-citation id="c9">Anderson, S.W., Rizzo, M., Skaar, N. et al., “Amnesia and Driving,” Journal of Clinical and Experimental Neuropsychology 29:1-12, 2007.</mixed-citation>
         </ref>
         <ref id="r10">
            <label>10.</label>
            <mixed-citation id="c10">Aksan, N., Hacker, S., Sager, L., Dawson, J. et al., “Correspondence between Simulator and On-Road Drive Performance: Implications for Assessment of Driving Safety,” Geriatrics 1:8, 2016.</mixed-citation>
         </ref>
         <ref id="r11">
            <label>11.</label>
            <mixed-citation id="c11">Rizzo, M., Sheffield, R.A., Stierman, L., and Dawson, J., “Demographic and Driving Performance Factors in Simulator Adaptation Syndrome,” 2003, Retrieved February 10, 2009, from http://ppc.iowa.uiowa.edu/driving-assessment/2003/Summaries/Downloads/Final_Papers/PDF/46_Rizzoformat.pdf.</mixed-citation>
         </ref>
         <ref id="r12">
            <label>12.</label>
            <mixed-citation id="c12">Stein, A.C. and Dubinsky, R.M., “Driving Simulator Performance in Patients with Possible and Probable Alzheimer’s Disease,” Annals of Advances in Automotive Medicine Association for the Advancement of Automotive Medicine Annual Scientific Conference 55:325-334, 2011.</mixed-citation>
         </ref>
         <ref id="r13">
            <label>13.</label>
            <mixed-citation id="c13">Uc, E.Y., Rizzo, M., Johnson, A.M., Dastrup, E. et al., “Road Safety in Drivers with Parkinson Disease,” Neurology 73:2112-2119, 2009.</mixed-citation>
         </ref>
         <ref id="r14">
            <label>14.</label>
            <mixed-citation id="c14">Kawano, N., Iwamoto, K., Ebe, K. et al., “Slower Adaptation to Driving Simulator and Simulator Sickness in Older Adults,” Aging Clinical and Experimental Research 24:285- 289, 2012.</mixed-citation>
         </ref>
      </ref-list>
   </back>
   <floats-group>
      <fig>
         <label>FIGURE 1</label>
         <caption id="ca-1">
            <p>Simulator for Interdisciplinary Research in Ergonomics and Neuroscience located at the University of Iowa. © 2019 SAE International. All Rights Reserved</p>
         </caption>
      </fig>
      <fig>
         <label>TABLE 1</label>
         <caption id="ca-2">
            <p>Characteristics of case drivers who could or could not complete the study, as well as controls. Values are means (SDs) or n (%). © 2019 SAE International. All Rights Reserved</p>
         </caption>
      </fig>
      <fig>
         <label>TABLE 2</label>
         <caption id="ca-3">
            <p>Means (SDs) and Wilcoxon Rank Sum p-values for case vs. control drivers (and p-values after adjusting for gender and age using partial Spearman correlations). © 2019 SAE International. All Rights Reserved</p>
         </caption>
      </fig>
      <fig>
         <label>TABLE 3</label>
         <caption id="ca-4">
            <p>Spearman correlations (p-values) for associations between five driving metrics and the total Charcot-Marie-Tooth Neuropathy Score version 2 for participants with Charcot-Marie-Tooth 1A (n = 18). © 2019 SAE International. All Rights Reserved</p>
         </caption>
      </fig>
      <fig>
         <label>TABLE 4</label>
         <caption id="ca-5">
            <p>Spearman correlation (p-values) for associations between components of the Charcot-Marie-Tooth Neuropathy Score version 2 and standard deviation of lateral position. © 2019 SAE International. All Rights Reserved</p>
         </caption>
      </fig>
   </floats-group>
</article>
